Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases
The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Compared to intravitreal injection, subretinal injection has more direct effects on the targeting cells in the subretinal space, which provides a new therapeutic method for vitreoretinal diseases, especially when gene therapy and/or cell therapy is involved. To date, subretinal delivery has been widely applied by scientists and clinicians as a more precise and efficient route of ocular drug delivery for gene therapies and cell therapies including stem cells in many degenerative vitreoretinal diseases, such as retinitis pigmentosa, age-related macular degeneration, and Leber's congenital amaurosis. However, clinicians should be aware of adverse events and possible complications when performing subretinal delivery. In the present review, the subretinal injection used in vitreoretinal diseases for basic research and clinical trials is summarized and described. Different methods of subretinal delivery, as well as its benefits and challenges, are also briefly introduced.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Subretinal drug is administered between the retinal photoreceptor cells and the RPE layer, requires less vector than intravitreal injections to achieve a therapeutic effect on the retina.127”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [127]
In the citing paper
“Despite these advantages, intravitreal injections also carry risks of adverse reactions, including inflammation, endophthalmitis, increased intraocular pressure, retinal detachment, hemorrhage, and cataracts, and due to the repeated use of these injections in various treatments, patient compliance can become an issue.119,127,129”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [127]
In the citing paper
“However, this route of administration can further damage an already damaged retina, leading to retinal or RPE detachment from underlying layers, hemorrhage, and changes in retinal pigmentation.35,127,128”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [127]
In the citing paper
“Most gene therapy viral vectors given intravitreally, fail to adequately transduce photoreceptors and RPE, due to the inner limiting membrane that divides the vitreous from the retina.1,15,119,127”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [127]
Citations
Cites
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Embryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
Ghasemi Falavarjani, K., & Nguyen, Q. D. (2013) · Eye · doi:10.1038/eye.2013.107 · Cited by 982
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
Intravitreal Aflibercept for Diabetic Macular Edema
Korobelnik, J.-F., Do, D. V., Schmidt-Erfurth, U., Boyer, D. S., Holz, F. G., Heier, J. S., Midena, E., Kaiser, P. K., Terasaki, H., Marcus, D. M., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.006 · Cited by 816
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Kamao, H., Mandai, M., Okamoto, S., Sakai, N., Suga, A., Sugita, S., Kiryu, J., & Takahashi, M. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.12.007 · Cited by 592
Acland, G. M., Aguirre, G. D., Bennett, J., Aleman, T. S., Cideciyan, A. V., Bennicelli, J., Dejneka, N. S., Pearce-Kelling, S. E., Maguire, A. M., Palczewski, K., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.008 · Cited by 477
Acute endophthalmitis following intravitreal triamcinolone acetonide injection
Moshfeghi, D. M., Kaiser, P. K., Scott, I. U., Sears, J. E., Benz, M., Sinesterra, J. P., Kaiser, R. S., Bakri, S. J., Maturi, R. K., Belmont, J., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00483-5 · Cited by 397
Testa, F., Maguire, A. M., Rossi, S., Pierce, E. A., Melillo, P., Marshall, K., Banfi, S., Surace, E. M., Sun, J., Acerra, C., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.11.048 · Cited by 330
Shirai, H., Mandai, M., Matsushita, K., Kuwahara, A., Yonemura, S., Nakano, T., Assawachananont, J., Kimura, T., Saito, K., Terasaki, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512590113 · Cited by 321
Simó, R., Sundstrom, J. M., & Antonetti, D. A. (2014) · Diabetes Care · doi:10.2337/dc13-2002 · Cited by 280
A review of anti-VEGF agents for proliferative diabetic retinopathy
Osaadon, P., Fagan, X. J., Lifshitz, T., & Levy, J. (2014) · Eye · doi:10.1038/eye.2014.13 · Cited by 265
Schwartz, S. D., Tan, G., Hosseini, H., & Nagiel, A. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-18681 · Cited by 245
Safety evaluation of ocular drug delivery formulations: Techniques and practical considerations
Short, B. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310955 · Cited by 244
Ghazi, N. G., Abboud, E. B., Nowilaty, S. R., Alkuraya, H., Alhommadi, A., Cai, H., Hou, R., Deng, W.-T., Boye, S. L., Almaghamsi, A., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1637-y · Cited by 243
Drug delivery systems for vitreoretinal diseases
Yasukawa, T., Ogura, Y., Tabata, Y., Kimura, H., Wiedemann, P., & Honda, Y. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.02.003 · Cited by 232
Jacobson, S. G., Acland, G. M., Aguirre, G. D., Aleman, T. S., Schwartz, S. B., Cideciyan, A. V., Zeiss, C. J., Komaromy, A. M., Kaushal, S., Roman, A. J., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.005 · Cited by 224
Weber, M., Rabinowitz, J., Provost, N., Conrath, H., Folliot, S., Briot, D., Chérel, Y., Chenuaud, P., Samulski, J., Moullier, P., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00098-4 · Cited by 203
Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis
Cideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., Windsor, E. A. M., Conlon, T. J., Sumaroka, A., Roman, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0903652 · Cited by 199
Rakoczy, E. P., Lai, C.-M., Magno, A. L., Wikstrom, M. E., French, M. A., Pierce, C. M., Schwartz, S. D., Blumenkranz, M. S., Chalberg, T. W., Degli-Esposti, M. A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00345-1 · Cited by 189
(2008) · PubMed Central · Cited by 183
Kanemura, H., Go, M. J., Shikamura, M., Nishishita, N., Sakai, N., Kamao, H., Mandai, M., Morinaga, C., Takahashi, M., & Kawamata, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085336 · Cited by 181
Stanzel, B. V., Liu, Z., Somboonthanakij, S., Wongsawad, W., Brinken, R., Eter, N., Corneo, B., Holz, F. G., Temple, S., Stern, J. H., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.005 · Cited by 168
Development of human embryonic stem cell therapies for age-related macular degeneration
Carr, A.-J. F., Smart, M. J. K., Ramsden, C. M., Powner, M. B., da Cruz, L., & Coffey, P. J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.03.006 · Cited by 167
Costa, R. A., Jorge, R., Calucci, D., Cardillo, J. A., Melo, L. A. S., & Scott, I. U. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0433 · Cited by 165
Gene therapy progress and prospects: the eye
Bainbridge, J. W., Tan, M. H., & Ali, R. R. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302812 · Cited by 162
Vujosevic, S., Torresin, T., Bini, S., Convento, E., Pilotto, E., Parrozzani, R., & Midena, E. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13294 · Cited by 160
Hillenkamp, J., Surguch, V. K., Framme, C., Gabel, V., & Sachs, H. G. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1158-7 · Cited by 159
Sugita, S., Iwasaki, Y., Makabe, K., Kamao, H., Mandai, M., Shiina, T., Ogasawara, K., Hirami, Y., Kurimoto, Y., & Takahashi, M. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.010 · Cited by 156
Pfeffer, B., Wiggert, B., Lee, L., Zonnenberg, B., Newsome, D., & Chader, G. (1983) · Journal of Cellular Physiology · doi:10.1002/jcp.1041170308 · Cited by 148
Gemenetzi, M. K., Lotery, A. J., & Patel, P. J. (2016) · Eye · doi:10.1038/eye.2016.208 · Cited by 145
Choonara, Y. E., Pillay, V., Danckwerts, M. P., Carmichael, T. R., & du Toit, L. C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21987 · Cited by 142
Amado, D., Mingozzi, F., Hui, D., Bennicelli, J. L., Wei, Z., Chen, Y., Bote, E., Grant, R. L., Golden, J. A., Narfstrom, K., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000659 · Cited by 140
Tzameret, A., Sher, I., Belkin, M., Treves, A. J., Meir, A., Nagler, A., Levkovitch-Verbin, H., Barshack, I., Rosner, M., & Rotenstreich, Y. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.10.023 · Cited by 138
Hu, Y., Liu, L., Lü, B., Zhu, D., Ribeiro, R., Diniz, B. C., Thomas, P. B., Ahuja, A., Hinton, D. R., Tai, Y., et al. (2012) · Ophthalmic Research · doi:10.1159/000338749 · Cited by 123
Chen, S.-N., Lian, I., Hwang, Y.-C., Chen, Y., Chang, Y.-C., Lee, K.-H., Chuang, C., & Wu, W. (2014) · Retina · doi:10.1097/iae.0000000000000380 · Cited by 122
Little, C. W., Castillo, B. V., DiLoreto, D. A., Cox, C., Wyatt, J. D., del Cerro, C., & del Cerro, M. (1996) · PubMed · Cited by 115
Subretinal injections in rodent eyes: effects on electrophysiology and histology of rat retina.
Timmers, A. M., Zhang, H., Squitieri, A., & Gonzalez-Pola, C. (2001) · PubMed · Cited by 110
Conlon, T. J., Deng, W., Erger, K. E., Cossette, T. L., Pang, J., Ryals, R. C., Clément, N., Cleaver, B. D., McDoom, I., Boye, S. L., et al. (2013) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2013.037 · Cited by 104
Klassen, H. J., Kiilgaard, J. F., Zahir, T., Ziaeian, B., Kirov, I. I., Scherfig, E., Warfvinge, K., & Young, M. J. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0541 · Cited by 102
Maia, M., Kellner, L., de Juan, E., Smith, R. L., Farah, M. E., Margalit, E., Lakhanpal, R. R., Grebe, L., Eong, K. A., & Humayun, M. S. (2004) · Retina · doi:10.1097/00006982-200402000-00012 · Cited by 101
Non-viral ocular gene therapy: Potential ocular therapeutic avenues
Bloquel, C., Bourges, J., Touchard, E., Berdugo, M., BenEzra, D., & Béhar‐Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.023 · Cited by 93
Koss, M., Falabella, P., Stefanini, F. R., Pfister, M., Thomas, B. B., Kashani, A. H., Brant, R., Zhu, D., Clegg, D., Hinton, D. R., et al. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3386-y · Cited by 92
Emre, E., Yüksel, N., Duruksu, G., Pirhan, D., Subaşı, C., Erman, G., & Karaöz, E. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2014.12.005 · Cited by 91
Schlichtenbrede, F. C., da Cruz, L., Stephens, C., Smith, A. J., Georgiadis, A., Thrasher, A. J., Bainbridge, J. W., Seeliger, M. W., & Ali, R. R. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.401 · Cited by 87
Georgiadis, A., Duran, Y., Ribeiro, J., Abelleira-Hervas, L., Robbie, S. J., Sünkel-Laing, B., Fourali, S., Gonzalez-Cordero, A., Cristante, E., Michaelides, M., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.66 · Cited by 84
Subretinal Gene Therapy of Mice With Bardet-Biedl Syndrome Type 1
Seo, S., Mullins, R. F., Dumitrescu, A. V., Bhattarai, S., Gratie, D., Wang, K., Stone, E. M., Sheffield, V., & Drack, A. V. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-11673 · Cited by 83
Advances in AAV Vector Development for Gene Therapy in the Retina
Day, T. P., Byrne, L. C., Schaffer, D. V., & Flannery, J. G. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_86 · Cited by 78
Technical brief: subretinal injection and electroporation into adult mouse eyes.
Johnson, C. J., Berglin, L., Chrenek, M. A., Redmond, T. M., Boatright, J. H., & Nickerson, J. M. (2008) · PubMed Central · Cited by 69
Gene supplementation therapy for recessive forms of inherited retinal dystrophies
Smith, A. J., Bainbridge, J. W., & Ali, R. R. (2011) · Gene Therapy · doi:10.1038/gt.2011.161 · Cited by 66
Guan, Y., Cui, L., Qu, Z., Lü, L., Wang, F., Wu, Y., Zhang, J., Gao, F.-L., Tian, H., Xu, L., et al. (2013) · Current Molecular Medicine · doi:10.2174/15665240113139990071 · Cited by 65
Changes in adeno-associated virus-mediated gene delivery in retinal degeneration
Kolstad, K. D., Dalkara, D., Guerin, K., Visel, M., Hoffmann, N., Schaffer, D. V., & Flannery, J. G. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.194 · Cited by 63
Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates
Lai, C.-M., Estcourt, M. J., Himbeck, R. P., Lee, S.-Y., Yeo, I., Luu, C. D., Loh, B. K., Lee, M. W., Barathi, V. A., Villano, J., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.169 · Cited by 60
Barker, S. E., Broderick, C. A., Robbie, S. J., Duran, Y., Natkunarajah, M., Buch, P., Balaggan, K. S., MacLaren, R. E., Bainbridge, J. W. B., Smith, A. J., et al. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1327 · Cited by 59
Watanabe, S., Sanuki, R., Ueno, S., Koyasu, T., Hasegawa, T., & Furukawa, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054146 · Cited by 59
Ehlers, J. P., Petkovsek, D. S., Yuan, A., Singh, R. P., & Srivastava, S. K. (2015) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20150323-05 · Cited by 57
Jo, Y.-J., Sonoda, K.-H., Oshima, Y., Takeda, A., Kohno, R.-I., Yamada, J., Hamuro, J., Yang, Y., Notomi, S., Hisatomi, T., et al. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5189 · Cited by 55
Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa
Wert, K. J., Davis, R. J., Sancho-Pelluz, J., Nishina, P. M., & Tsang, S. H. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds466 · Cited by 55
Qi, Y., Dai, X., Zhang, H., He, Y., Zhang, Y., Han, J., Zhu, P., Zhang, Y., Zheng, Q., Li, X., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136523 · Cited by 54
Flachsbarth, K., Kruszewski, K., Jung, G., Jankowiak, W., Riecken, K., Wagenfeld, L., Richard, G., Fehse, B., & Bartsch, U. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-15266 · Cited by 54
Li, W., Kong, F., Li, X., Dai, X., Liu, X., Zheng, Q., Wu, R., Zhou, X., Lü, F., Chang, B., et al. (2009) · PubMed · Cited by 52
Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
Ausayakhun, S., Yuvaves, P., Ngamtiphakom, S., & Prasitsilp, J. (2005) · PubMed · Cited by 52
Amirpour, N., Karamali, F., Rabiee, F., Rezaei, L., Esfandiari, E., Razavi, S., Dehghani, A., Razmjoo, H., Nasr‐Esfahani, M. H., & Baharvand, H. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0073 · Cited by 50
Francis, P. J., Wang, S., Zhang, Y., Brown, A., Hwang, T. S., McFarland, T. J., Jeffrey, B. G., Lü, B., Wright, L. S., Appukuttan, B., et al. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2908 · Cited by 49
A new approach towards a minimal invasive retina implant
Gerding, H. (2007) · Journal of Neural Engineering · doi:10.1088/1741-2560/4/1/s05 · Cited by 46
Optimized Technique for Subretinal Injections in Mice
Mühlfriedel, R., Michalakis, S., Garrido, M. G., Biel, M., & Seeliger, M. W. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-080-9_24 · Cited by 44
Bollinger, K. E., & Smith, S. D. G. (2009) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32831d7f3a · Cited by 44
Xu, H., Zhang, L., Gu, L., Lü, L., Gao, G., Li, W., Xu, G., Wang, J., Gao, F., Xu, J., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13155 · Cited by 40
Murakami, Y., Ikeda, Y., Yonemitsu, Y., Miyazaki, M., Inoue, M., Hasegawa, M., Sueishi, K., & Ishibashi, T. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.102 · Cited by 40
Tracy, C. J., Whiting, R. E. H., Pearce, J. W., Williamson, B. G., Vansteenkiste, D. P., Gillespie, L. E., Castaner, L. J., Bryan, J. N., Coates, J. R., Jensen, C. A., et al. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.09.003 · Cited by 39
IL-10 Is Significantly Involved in HSP70-Regulation of Experimental Subretinal Fibrosis
Yang, Y., Takeda, A., Yoshimura, T., Oshima, Y., Sonoda, K.-H., & Ishibashi, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080288 · Cited by 38
Application of a New Subretinal Injection Device in the Dog
Komáromy, A. M., Varner, S. E., De Juan, E., Acland, G. M., & Aguirre, G. D. (2006) · Cell Transplantation · doi:10.3727/000000006783981701 · Cited by 37
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
Wert, K. J., Skeie, J. M., Davis, R. J., Tsang, S. H., & Mahajan, V. B. (2012) · Journal of Visualized Experiments · doi:10.3791/4286 · Cited by 37
Shao, J., Tian, L., Lei, B., Lin, W., Yang, Y., Kijlstra, A., & Yang, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037773 · Cited by 36
Retinal Detachment After Subretinal Stem Cell Transplantation
Leung, E. H., Flynn, H. W., Albini, T. A., & Medina, C. A. (2016) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20160601-16 · Cited by 36
Annear, M. J., Mowat, F. M., Bartoe, J. T., Querubin, J., Azam, S. A., Basche, M., Curran, P. G., Smith, A. J., Bainbridge, J. W. B., Ali, R. R., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.146 · Cited by 34
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Giocanti‐Auregan, A., Tadayoni, R., Grenet, T., Fajnkuchen, F., Nghiem‐Buffet, S., Delahaye-Mazza, C., Quentel, G., & Cohen, S. Y. (2016) · BMC Ophthalmology · doi:10.1186/s12886-016-0317-y · Cited by 32
Brant, R., Koss, M., Falabella, P., Stefanini, F. R., Maia, M., Diniz, B. C., Ribeiro, R., Hu, Y., Hinton, D. R., Clegg, D., et al. (2016) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20160324-07 · Cited by 29
De Silva, S. R., Charbel Issa, P., Singh, M. S., Lipinski, D. M., Barnea-Cramer, A. O., Walker, N. J., Barnard, A. R., Hankins, M. W., & MacLaren, R. E. (2016) · Gene Therapy · doi:10.1038/gt.2016.54 · Cited by 29
Bek, T., & Jørgensen, C. M. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20305 · Cited by 29
Jones, M. K., Lü, B., Saghizadeh, M., & Wang, S. (2016) · PubMed Central · Cited by 28
Tian, L., Lei, B., Shao, J., Wei, L., Kijlstra, A., & Yang, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037995 · Cited by 26
Subretinal Delivery and Electroporation in Pigmented and Nonpigmented Adult Mouse Eyes
Nickerson, J. M., Goodman, P., Chrenek, M. A., Bernal, C. J., Berglin, L., Redmond, T. M., & Boatright, J. H. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-848-1_4 · Cited by 25
Chatziralli, I., Nicholson, L., Sivaprasad, S., & Hykin, P. G. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1086744 · Cited by 24
Wojciechowski, A. B., Englund, U., Lundberg, C., & Warfvinge, K. (2002) · Stem Cells · doi:10.1634/stemcells.20-2-163 · Cited by 23
Hwang, D. D.-J., Kim, Y. W., Woo, S. J., & Park, K. H. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.12.1580 · Cited by 22
Ikeda, Y., Yonemitsu, Y., Miyazaki, M., Kohno, R.-I., Murakami, Y., Murata, T., Tabata, T., Ueda, Y., Ono, F., Suzuki, T., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.009 · Cited by 21
Parikh, S., Le, A. N., Davenport, J., Gorin, M. B., Nusinowitz, S., & Matynia, A. (2016) · Journal of Visualized Experiments · doi:10.3791/54808 · Cited by 20
Lambert, N. G., Zhang, X., Rai, R. R., Uehara, H., Choi, S., Carroll, L. S., Das, S. K., Cahoon, J. M., Kirk, B. H., Bentley, B. M., et al. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.01.009 · Cited by 19
Li, F., Zeng, Y., Xu, H., & Yin, Z. Q. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.05.004 · Cited by 17
Peng, Y., Zhang, Y., Huang, B. Q., Luo, Y., Zhang, M., Li, K., Li, W., Wen, W., & Tang, S. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666131219115125 · Cited by 16
Self-citationHuang, R., Baranov, P. Y., Lai, K., Zhang, X., Ge, J., & Young, M. J. (2014) · Europe PMC (PubMed Central) · Cited by 14
Subretinal Gene Delivery Using Helper-Dependent Adenoviral Vectors
Wu, L., Lam, S., Cao, H., Guan, R., Duan, R., van der Kooy, D., Bremner, R., Molday, R. S., & Hu, J. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-15 · Cited by 13
Fitzgerald, J., Saunders, L., Ridge, B., White, A. J. R., Goldberg, I., Clark, B., Mills, R. A., & Craig, J. E. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12433 · Cited by 12
Jonas, J. B., & Rensch, F. (2008) · European Journal of Ophthalmology · doi:10.1177/112067210801800531 · Cited by 12
Dai, X., Zhang, H., Han, J., He, Y., Zhang, Y., Qi, Y., & Pang, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156542 · Cited by 10
Intravitreal Steroid Implants in the Management of Retinal Disease and Uveitis
Logan, S. A., Weng, C. Y., & Carvounis, P. E. (2016) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000132 · Cited by 8
Incidence of post-intravitreal anti-VEGF endophthalmitis at Thammasat University Hospital.
Kanchanaranya, N., Rojdamrongratana, D., & Piyasoonthorn, P. (2015) · PubMed · Cited by 7
Intravitreal steroid versus macular laser for treatment of diabetic macular edema
Gunther, J. B., & Ip, M. S. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0042-5 · Cited by 6
Huang, Q., Xu, P., Xia, X., Hu, H.-H., Wang, F., & Li, H. (2006) · PubMed · Cited by 6
Kubicka‐Trząska, A., Jędrychowska-Jamborska, J., Kulig-Stochmal, A., Morawski, K., & Romanowska-Dixon, B. (2015) · PubMed · Cited by 3
Cited by
Therapeutic in vivo delivery of gene editing agents
Raguram, A., Banskota, S., & Liu, D. R. (2022) · Cell · doi:10.1016/j.cell.2022.03.045 · Cited by 522
“, via subretinal injection) can circumvent biological barriers and enable access to certain important cell populations (Bottros and Christo, 2014; Peng et al., 2017).”
BackgroundVarela-Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García-Otero, X., Luzardo-Álvarez, A., Fernández-Ferreiro, A., & Otero-Espinar, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030269 · Cited by 354
“Subretinal delivery can also be used for stem cell transplantation in ocular degenerative diseases, which was reported in vivo studies and aimed at clinical applications [224].”
BackgroundMethodInfluentialMammalian Near-Infrared Image Vision through Injectable and Self-Powered Retinal Nanoantennae
Ma, Y., Bao, J., Zhang, Y., Li, Z., Zhou, X., Wan, C., Huang, L., Zhao, Y., Han, G., & Xue, T. (2019) · Cell · doi:10.1016/j.cell.2019.01.038 · Cited by 292
“As sub-retinal injections are a commonly used ophthalmological practice in animals and humans (Hauswirth et al., 2008; Peng et al., 2017), our pbUCNPs were dissolved in PBS and then injected into the sub-retinal space in the eyes of mice.”
The effects of PEGylation on LNP based mRNA delivery to the eye
Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241006 · Cited by 194
“Specific to treating the retina, clinicians and scientists are in much debate over the visual impact of detaching the fovea and/or a fragile degenerating retina during a subretinal injection [6].”
BackgroundGasparini, S. J., Llonch, S., Borsch, O., & Ader, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.11.001 · Cited by 186
Metadata
- Authors
- Peng, Y., Tang, L., & Zhou, Y.
- Affiliations
- Central South University (CN)
- Venue
- Ophthalmic Research
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 58
- Issue
- 4
- Pages
- 217-226
- ISSN
- 0030-3747 (ISSN-L)
- 1423-0259
- OpenAlex
- W2752393253
- Cited by
- 175
- References
- 108
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 27 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 15 · 2019: 14 · 2018: 6
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Ophthalmic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- subretinal injection, ocular drug delivery, vitreoretinal disease, gene therapy, cell therapy, stem cell therapy, retinitis pigmentosa, age-related macular degeneration, Leber congenital amaurosis, degenerative retinal diseases, injection complications
- MeSH terms
- Animals, Genetic Vectors, Humans, Injections, Retina, Retinal Diseases, Genetic Therapy, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.